Provided by Tiger Trade Technology Pte. Ltd.

NovoCure

17.10
-0.6700-3.77%
Post-market: 17.550.4500+2.63%19:30 EDT
Volume:1.40M
Turnover:24.25M
Market Cap:1.99B
PE:-13.07
High:17.83
Open:17.75
Low:17.01
Close:17.77
52wk High:21.45
52wk Low:9.82
Shares:116.45M
Float Shares:96.42M
Volume Ratio:0.81
T/O Rate:1.46%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3082
EPS(LYR):-1.2221
ROE:-43.22%
ROA:-9.26%
PB:5.89
PE(LYR):-13.99

Loading ...

Novocure Q2 Pretax Profit USD -12.452 Million

THOMSON REUTERS
·
Jul 23

Novocure Q2 Revenue USD 183.584 Million VS. Ibes Estimate USD 172.4 Million

THOMSON REUTERS
·
Jul 23

Novocure Reports Second Quarter 2026 Financial Results

THOMSON REUTERS
·
Jul 23

Earning Preview: NovoCure revenue is expected to increase by 12.00%, institutions lean cautious on near-term profitability

Earnings Agent
·
Jul 17

Analysts Have Conflicting Sentiments on These Healthcare Companies: COMPASS Pathways (CMPS), NovoCure (NVCR) and Bristol-Myers Squibb (BMY)

TIPRANKS
·
Jul 13

Novocure Price Target Announced at $17.00/share by JP Morgan

Dow Jones
·
Jul 13

J.P. Morgan Sticks to Its Hold Rating for NovoCure (NVCR)

TIPRANKS
·
Jul 13

Novocure Ltd : JP Morgan Resumes Coverage with Neutral Rating; Target Price $17

THOMSON REUTERS
·
Jul 13

Novocure to Report Q2 Results, Host Conference Call and Webcast

Reuters
·
Jul 01

Novocure to Report Second Quarter 2026 Financial Results

THOMSON REUTERS
·
Jul 01

Novocure Wins CE Mark for Optune Pax in Locally Advanced Pancreatic Cancer Treatment

Reuters
·
Jun 30

Novocure’s Optune Pax® Receives Ce Mark for the Treatment of Locally Advanced Pancreatic Cancer

THOMSON REUTERS
·
Jun 30

Novocure - to Launch Optune Pax in Germany in Coming Weeks

THOMSON REUTERS
·
Jun 30

Wedbush Initiates a Hold Rating on NovoCure (NVCR)

TIPRANKS
·
Jun 23

Analysts Are Bullish on These Healthcare Stocks: NovoCure (NVCR), Ocular Therapeutix (OCUL)

TIPRANKS
·
Jun 22

Top Midday Decliners

MT Newswires Live
·
Jun 19

Sector Update: Healthcare Stocks Decline Thursday Afternoon

MT Newswires Live
·
Jun 19

NovoCure Down Nearly 18%, On Track for Largest Percent Decrease Since July 2025 -- Data Talk

Dow Jones
·
Jun 19

Novocure Price Target Cut to $46.00/Share From $48.00 by HC Wainwright & Co.

Dow Jones
·
Jun 19

BUZZ-U.S. STOCKS ON THE MOVE-Kardigan, Energy companies

Reuters
·
Jun 18